NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $0.17 -0.01 (-4.59%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.17 0.00 (-0.87%) As of 03/28/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About P3 Health Partners Stock (NASDAQ:PIII) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get P3 Health Partners alerts:Sign Up Key Stats Today's Range$0.16▼$0.1850-Day Range$0.16▼$0.2452-Week Range$0.15▼$1.02Volume695,050 shsAverage Volume979,380 shsMarket Capitalization$61.90 millionP/E RatioN/ADividend YieldN/APrice Target$0.25Consensus RatingHold Company OverviewP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Read More… Remove Ads P3 Health Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScorePIII MarketRank™: P3 Health Partners scored higher than 39% of companies evaluated by MarketBeat, and ranked 727th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingP3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has received no research coverage in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.67) to ($0.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.56% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently increased by 37.65%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.56% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently increased by 37.65%, indicating that investor sentiment is decreasing significantly. News and Social Media0.9 / 5News Sentiment-0.34 News SentimentP3 Health Partners has a news sentiment score of -0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for P3 Health Partners this week, compared to 1 article on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders15.76% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address PIII Stock News HeadlinesP3 Health Partners (PIII) Gets a Hold from TD CowenMarch 29 at 12:59 AM | markets.businessinsider.comP3 Health Partners backs FY25 revenue view $1.35B-$1.5B, consensus $1.4BMarch 28 at 2:57 PM | markets.businessinsider.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. March 30, 2025 | Golden Portfolio (Ad)William Blair Sticks to Their Buy Rating for P3 Health Partners (PIII)March 28 at 2:57 PM | markets.businessinsider.comP3 Health Partners posts wider-than-expected Q4 loss, revenue miss; Shares fallMarch 27 at 9:30 PM | investing.comP3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call TranscriptMarch 27 at 9:00 PM | seekingalpha.comP3 Health Partners Announces Fourth Quarter and Full Year 2024 ResultsMarch 27 at 4:22 PM | businesswire.comP3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27March 13, 2025 | finance.yahoo.comSee More Headlines PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $0.2249 on January 1st, 2025. Since then, PIII stock has decreased by 23.3% and is now trading at $0.1725. View the best growth stocks for 2025 here. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) released its quarterly earnings results on Thursday, March, 27th. The company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.15. The company earned $370.69 million during the quarter, compared to analyst estimates of $378.88 million. P3 Health Partners had a negative trailing twelve-month return on equity of 71.31% and a negative net margin of 6.95%. Who are P3 Health Partners' major shareholders? Top institutional investors of P3 Health Partners include Alyeska Investment Group L.P. (3.32%), Corient Private Wealth LLC (0.35%), Trinity Financial Advisors LLC (0.29%) and Geode Capital Management LLC (0.26%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou and Atul Kavthekar. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of P3 Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), PayPal (PYPL), TriNet Group (TNET), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV) and 3M (MMM). Company Calendar Last Earnings3/27/2025Today3/30/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Stock Price Target$0.25 High Stock Price Target$0.25 Low Stock Price Target$0.25 Potential Upside/Downside+44.9%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-57,770,000.00 Net Margins-6.95% Pretax Margin-16.87% Return on Equity-71.31% Return on Assets-11.93% Debt Debt-to-Equity Ratio1.11 Current Ratio0.53 Quick Ratio0.53 Sales & Book Value Annual Sales$1.48 billion Price / Sales0.04 Cash Flow$0.07 per share Price / Cash Flow2.32 Book Value$0.45 per share Price / Book0.38Miscellaneous Outstanding Shares358,820,000Free Float294,735,000Market Cap$61.90 million OptionableNot Optionable Beta0.94 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:PIII) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.